Similar articles for PMID: 28572223

Year	Number of Results
1999	1
2002	3
2003	2
2004	2
2005	5
2006	1
2007	4
2008	4
2009	7
2010	4
2011	3
2012	4
2013	3
2014	6
2015	6
2016	7
2017	7
2018	13
2019	10
2021	1
2024	0

1

Developments in therapy with monoclonal antibodies and related proteins.

Shepard HM, Phillips GL, D Thanos C, Feldmann M. Shepard HM, et al. Clin Med (Lond). 2017 Jun;17(3):220-232. doi: 10.7861/clinmedicine.17-3-220. Clin Med (Lond). 2017. PMID: 28572223 Free PMC article. Review.

2

Therapeutic monoclonal antibodies in ophthalmology.

Rodrigues EB, Farah ME, Maia M, Penha FM, Regatieri C, Melo GB, Pinheiro MM, Zanetti CR. Rodrigues EB, et al. Prog Retin Eye Res. 2009 Mar;28(2):117-44. doi: 10.1016/j.preteyeres.2008.11.005. Epub 2008 Dec 10. Prog Retin Eye Res. 2009. PMID: 19114125 Review.

3

The pharmacology and therapeutic applications of monoclonal antibodies.

Castelli MS, McGonigle P, Hornby PJ. Castelli MS, et al. Pharmacol Res Perspect. 2019 Dec;7(6):e00535. doi: 10.1002/prp2.535. Pharmacol Res Perspect. 2019. PMID: 31859459 Free PMC article. Review.

4

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

Silberstein S, Lenz R, Xu C. Silberstein S, et al. Headache. 2015 Sep;55(8):1171-82. doi: 10.1111/head.12642. Epub 2015 Aug 28. Headache. 2015. PMID: 26316307 Review.

5

New monoclonal antibodies in renal transplantation.

Vincenti F. Vincenti F. Minerva Urol Nefrol. 2003 Mar;55(1):57-66. Minerva Urol Nefrol. 2003. PMID: 12773967 Review.

6

Immuno-PET: a navigator in monoclonal antibody development and applications.

van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. van Dongen GA, et al. Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379. Oncologist. 2007. PMID: 18165614 Free article. Review.

7

Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.

Brennan FR, Cauvin A, Tibbitts J, Wolfreys A. Brennan FR, et al. Drug Dev Res. 2014 May;75(3):115-61. doi: 10.1002/ddr.21173. Epub 2014 Apr 29. Drug Dev Res. 2014. PMID: 24782266 Review.

8

Fundamentals of antibody-related therapy and diagnostics.

Albrecht H, Radosevich JA, Babich M. Albrecht H, et al. Drugs Today (Barc). 2009 Mar;45(3):199-211. doi: 10.1358/dot.2009.45.3.1341343. Drugs Today (Barc). 2009. PMID: 19436842 Review.

9

The next generation of antibody-drug conjugates comes of age.

Beck A, Haeuw JF, Wurch T, Goetsch L, Bailly C, Corvaïa N. Beck A, et al. Discov Med. 2010 Oct;10(53):329-39. Discov Med. 2010. PMID: 21034674 Free article. Review.

10

Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies.

Johnson DE. Johnson DE. Int J Mol Sci. 2018 Nov 21;19(11):3685. doi: 10.3390/ijms19113685. Int J Mol Sci. 2018. PMID: 30469350 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year